Artrya Statistics
Total Valuation
Artrya has a market cap or net worth of AUD 229.40 million. The enterprise value is 218.69 million.
Market Cap | 229.40M |
Enterprise Value | 218.69M |
Important Dates
The last earnings date was Monday, July 28, 2025.
Earnings Date | Jul 28, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Artrya has 117.64 million shares outstanding. The number of shares has increased by 17.39% in one year.
Current Share Class | 117.64M |
Shares Outstanding | 117.64M |
Shares Change (YoY) | +17.39% |
Shares Change (QoQ) | +26.28% |
Owned by Insiders (%) | 24.29% |
Owned by Institutions (%) | 3.39% |
Float | 79.77M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 16.25 |
PS Ratio | 8,192.72 |
PB Ratio | 10.78 |
P/TBV Ratio | 14.16 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -13.33 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -15.05 |
Financial Position
The company has a current ratio of 8.27, with a Debt / Equity ratio of 0.03.
Current Ratio | 8.27 |
Quick Ratio | 8.07 |
Debt / Equity | 0.03 |
Debt / EBITDA | n/a |
Debt / FCF | -0.04 |
Interest Coverage | -573.03 |
Financial Efficiency
Return on equity (ROE) is -86.14% and return on invested capital (ROIC) is -52.37%.
Return on Equity (ROE) | -86.14% |
Return on Assets (ROA) | -48.66% |
Return on Invested Capital (ROIC) | -52.37% |
Return on Capital Employed (ROCE) | -76.92% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | 0.00 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, Artrya has paid 29,000 in taxes.
Income Tax | 29,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +504.69% in the last 52 weeks. The beta is 0.20, so Artrya's price volatility has been lower than the market average.
Beta (5Y) | 0.20 |
52-Week Price Change | +504.69% |
50-Day Moving Average | 1.13 |
200-Day Moving Average | 0.80 |
Relative Strength Index (RSI) | 71.24 |
Average Volume (20 Days) | 767,890 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Artrya had revenue of AUD 28,000 and -16.41 million in losses. Loss per share was -0.18.
Revenue | 28,000 |
Gross Profit | -15.99M |
Operating Income | -16.62M |
Pretax Income | -16.38M |
Net Income | -16.41M |
EBITDA | -16.21M |
EBIT | -16.62M |
Loss Per Share | -0.18 |
Balance Sheet
The company has 11.33 million in cash and 624,000 in debt, giving a net cash position of 10.71 million or 0.09 per share.
Cash & Cash Equivalents | 11.33M |
Total Debt | 624,000 |
Net Cash | 10.71M |
Net Cash Per Share | 0.09 |
Equity (Book Value) | 21.29M |
Book Value Per Share | 0.19 |
Working Capital | 15.06M |
Cash Flow
In the last 12 months, operating cash flow was -14.27 million and capital expenditures -263,000, giving a free cash flow of -14.53 million.
Operating Cash Flow | -14.27M |
Capital Expenditures | -263,000 |
Free Cash Flow | -14.53M |
FCF Per Share | -0.12 |
Margins
Gross Margin | n/a |
Operating Margin | -59,350.00% |
Pretax Margin | -58,489.29% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
Artrya does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -17.39% |
Shareholder Yield | n/a |
Earnings Yield | -7.15% |
FCF Yield | -6.34% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Artrya has an Altman Z-Score of 8.35 and a Piotroski F-Score of 2.
Altman Z-Score | 8.35 |
Piotroski F-Score | 2 |